Literature DB >> 10799450

Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting.

P T Marcolino1, D A Silva, P G Leser, M E Camargo, J R Mineo.   

Abstract

We characterized antigenic markers recognized by human serum samples from patients presenting with acute and chronic toxoplasmosis by the determination of immunoglobulin G (IgG) antibody avidity by a Western blot modified technique (avidity immunoblotting) that includes the dissociation of the antigen-antibody interaction with 6 or 8 M urea solutions. Human serum samples from 20 patients presenting with recent infection and from 20 patients with chronic infection were analyzed. It was observed that bands p16, p32, p38, p40, p43, p54, p60, p66, and p97 were more frequently recognized by low-avidity IgG in recent infection and by high-avidity IgG in chronic toxoplasmosis. From these antigenic bands, p38 can be characterized as an optimal antigenic marker of low avidity for recent forms of toxoplasmosis due to a significant decrease of their frequencies (from 80 to 0%) after treatment with 6 M urea solutions. The p30 antigen was not considered a good marker to distinguish acute from chronic infection since corresponding IgG antibodies were determined to have high avidity in both phases of the infection. Thus, the avidity immunoblotting assay proved to be a useful tool for determining antigenic markers of recent and chronic phases of Toxoplasma gondii infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799450      PMCID: PMC95883          DOI: 10.1128/CDLI.7.3.384-389.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  13 in total

1.  A new method with general diagnostic utility for the calculation of immunoglobulin G avidity.

Authors:  M H Korhonen; J Brunstein; H Haario; A Katnikov; R Rescaldani; K Hedman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Demonstration of antigenic similarities and variations in excretory/secretory antigens of Toxoplasma gondii.

Authors:  N Rahmah; A K Anuar
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

3.  Potential role of IgG avidity for diagnosing toxoplasmosis.

Authors:  D H Joynson; R A Payne; B K Rawal
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Analysis of aqueous humor in ocular toxoplasmosis: detection of low avidity IgG specific to Toxoplasma gondii.

Authors:  F A Vinhal; J D Pena; J H Katina; E O Brandao; D A Silva; F Orefice; J R Mineo
Journal:  Appl Parasitol       Date:  1994-02

7.  Role of serology in the diagnosis of toxoplasmic lymphadenopathy.

Authors:  R G Brooks; R E McCabe; J S Remington
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

8.  [Avidity of specific IgG antibodies as markers of recent primary infection caused by Toxoplasma gondii].

Authors:  M E Camargo; S M da Silva; P G Leser; C H Granato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 May-Jun       Impact factor: 1.846

9.  The diagnosis of toxoplasmosis using IgG avidity.

Authors:  R E Holliman; R Raymond; N Renton; J D Johnson
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

10.  Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; M Lappalainen; I Seppäiä; O Mäkelä
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

View more
  30 in total

1.  Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.

Authors:  Lucyna Holec; Elzbieta Hiszczyńska-Sawicka; Artur Gasior; Anna Brillowska-Dabrowska; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis.

Authors:  H Pietkiewicz; E Hiszczyńska-Sawicka; J Kur; E Petersen; H V Nielsen; M Paul; M Stankiewicz; P Myjak
Journal:  Parasitol Res       Date:  2006-08-08       Impact factor: 2.289

4.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

5.  Antibody maturation in Trypanosoma cruzi-infected rats.

Authors:  I S Marcipar; M G Risso; A M Silber; S Revelli; A J Marcipar
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

6.  Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.

Authors:  Ai Ying Teh; Atefeh Amerizadeh; Sabariah Osman; Muhammad Hafiznur Yunus; Rahmah Noordin
Journal:  Pathog Glob Health       Date:  2016-10-04       Impact factor: 2.894

7.  Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy.

Authors:  Elisa Beghetto; Wilma Buffolano; Andrea Spadoni; Mariassunta Del Pezzo; Manlio Di Cristina; Olga Minenkova; Eskild Petersen; Franco Felici; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.

Authors:  V Meroni; F Genco; C Tinelli; P Lanzarini; L Bollani; M Stronati; E Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

9.  Seroprevalence of toxoplasmosis, toxocariasis and cysticercosis in a rural settlement, São Paulo State, Brazil.

Authors:  Luiz Euribel Prestes-Carneiro; Guita Rubinsky-Elefant; Antonio Walter Ferreira; Patricia Regina Araujo; Charlene Troiani; Sueli Cristina Zago; Marcia Kaiahara; Leticia Sasso; Alberto Iha; Adelaide Vaz
Journal:  Pathog Glob Health       Date:  2013-03       Impact factor: 2.894

10.  GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis.

Authors:  Lucyna Holec-Gasior; Józef Kur; Elzbieta Hiszczyńska-Sawicka
Journal:  Clin Vaccine Immunol       Date:  2009-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.